The Effect of Gender-Affirming Hormone Therapy on the Risk of Subclinical Atherosclerosis in the Transgender Population: A Systematic Review
- 2 January 2023
- journal article
- review article
- Published by Elsevier in Endocrine Practice
- Vol. 29 (6) , 498-507
Abstract
No abstract availableKeywords
Funding Information
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (INCT/CNPq 465482/2014–7)
- Fundação de Amparo à Pesquisa do Estado do Rio Grande do Sul
This publication has 52 references indexed in Scilit:
- A long-term follow-up study of mortality in transsexuals receiving treatment with cross-sex hormonesEuropean Journal of Endocrinology, 2011
- Effects of high dose oestrogen therapy on circulating inflammatory markersMaturitas, 2009
- Both a combined oral contraceptive and depot medroxyprogesterone acetate impair endothelial function in young womenContraception, 2009
- Increased arterial stiffness in female‐to‐male transsexuals treated with androgenJournal of Obstetrics and Gynaecology Research, 2008
- The effect of oestrogen on cytokine and antioxidant levels in male to female transsexual patientsMaturitas, 2006
- PAI‐1 and atherothrombosisJournal of Thrombosis and Haemostasis, 2005
- Interleukins in Atherosclerosis: Molecular Pathways and Therapeutic PotentialPharmacological Reviews, 2003
- Long-Term Use of Contraceptive Depot Medroxyprogesterone Acetate in Young Women Impairs Arterial Endothelial Function Assessed by Cardiovascular Magnetic ResonanceCirculation, 2002
- Restoration of endothelium-dependent relaxation by dietary treatment of atherosclerosis.Journal of Clinical Investigation, 1987
- Biologic Effects of Transdermal EstradiolNew England Journal of Medicine, 1986